Related Experiment Video
Updated: Sep 13, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Effect of Tau Fragment and Membrane Interactions on Membrane Permeabilization and Peptide Aggregation
Majedul Islam1, Md Raza Ul Karim1, Emily Argueta1
1Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431, USA.
Abstract:
Aggregation of tau protein is a hallmark feature of tauopathies such as Alzheimer's disease. The microtubule-binding domain of tau plays a crucial role in the tau aggregation process. In this study, we investigated the dual effects of membrane interactions of tau298-317, a fragment peptide from the microtubule-binding domain, on peptide-induced membrane disruption and membrane-mediated peptide self-assembly. Our results show that neither wild-type tau298-317 nor its P301L or Ser305-phosphorylated mutants aggregate in the presence of zwitterionic POPC vesicles or cause lipid vesicle leakage, indicating weak peptide-membrane interactions. In contrast, tau298-317 strongly interacts with negatively charged POPG liposomes, leading to a rapid transition of the peptide conformation from random coils to α-helical intermediate conformation upon membrane adsorption, which may further promote peptide self-association to form oligomers and β-sheet-rich fibrillar structures. Tau298-317-induced rapid POPG membrane leakage indicates a synergistic process of the peptide self-assembly at the membrane interface and the aggregation-induced membrane disruption. Notably, phosphorylation at Ser305 disrupts favorable electrostatic interactions between the peptide and POPG membrane surface, thus preventing peptide aggregation and membrane leakage. In contrast, the P301L mutation significantly enhances membrane-mediated peptide aggregation and peptide-induced membrane disruption, likely due to alleviation of local conformational constraints and enhancement of local hydrophobicity, which facilitates fast conformational conversion to β-sheet structures. These findings provide mechanistic insights into the molecular mechanisms underlying membrane-mediated aggregation of crucial regions of tau and peptide-induced membrane damage, indicating potential strategies to prevent tau aggregation and membrane rupture by targeting critical electrostatic interactions between membranes and key local regions of tau.
Insights
Tau peptide fragments aggregate on negatively charged membranes, causing disruption. Phosphorylation prevents aggregation, while a P301L mutation enhances it, offering insights into tauopathies.
Area of Science:
- Biochemistry
- Neuroscience
- Membrane Biophysics
Background:
- Tau protein aggregation is central to tauopathies, including Alzheimer's disease.
- The microtubule-binding domain of tau is critical for its aggregation.
- Membrane interactions are increasingly recognized as key modulators of tau aggregation.
Purpose of the Study:
- To investigate the dual role of membrane interactions of the tau298-317 peptide fragment in membrane disruption and self-assembly.
- To elucidate the effects of specific mutations (P301L) and phosphorylation (Ser305) on membrane-mediated tau aggregation.
Main Methods:
- Utilized zwitterionic (POPC) and negatively charged (POPG) lipid vesicles.
- Studied peptide conformation changes using spectroscopic methods.
- Assessed peptide-induced membrane leakage and aggregation.
Main Results:
- Wild-type and mutant tau298-317 showed weak interactions with POPC vesicles.
- Tau298-317 strongly interacted with POPG liposomes, inducing α-helical to β-sheet conformational changes and aggregation.
- POPG membrane leakage was observed, indicating synergistic peptide self-assembly and membrane disruption.
- Ser305 phosphorylation inhibited aggregation and leakage by disrupting electrostatic interactions.
- The P301L mutation enhanced aggregation and membrane disruption.
Conclusions:
- Membrane charge critically influences tau298-317 aggregation and membrane disruption.
- Specific modifications like phosphorylation and mutations alter tau-membrane interactions and aggregation propensity.
- Findings offer mechanistic insights into tau aggregation and suggest strategies targeting membrane interactions to prevent tauopathies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Mechanisms of Membrane Domain Formation
Another mechanism for membrane domain formation involves membrane proteins interacting with...
Protein Diffusion in the Membrane
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

